Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted.
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- New Endogenous Opioid Peptides and Peptidomimetics with Potential Biological Importance (Deadline: 20 May 2024)
- Telomere Length and Cardiovascular Disease: A Precursor Marker and Therapeutic Target (Deadline: 22 May 2024)
- Cell Fate Manipulation for Bone and Cartilage Reconstruction (Deadline: 31 May 2024)
- New Advances in Mesenchymal Stromal Cells as Therapeutic Tools (Deadline: 31 May 2024)
- Antimicrobial Peptides: Design, Synthesis and Pharmaceutical Applications (Deadline: 20 June 2024)
- Design, Synthesis, and Evaluation of Nucleobase, Nucleoside, and Nucleotide Analogues (Deadline: 20 June 2024)
- Phage Discovery and Phage Therapy (Deadline: 20 June 2024)
- HIV and Viral Hepatitis: Prevention, Treatment and Coinfection (Deadline: 24 June 2024)
- Glycans and Glycan-Binding Proteins in Drug Research (Deadline: 28 June 2024)
- The 20th Anniversary of Pharmaceuticals: Advances in Peptide Drug Design and Development: From Sequences to Drug Candidates (Deadline: 30 June 2024)
- The 20th Anniversary of Pharmaceuticals—Emerging Trends in Biopharmaceuticals (Deadline: 30 June 2024)
- The 20th Anniversary of Pharmaceuticals—The application of Adjuvants and Nanomaterials in Antimicrobial Intervention (Deadline: 25 July 2024)
- Pharmaceutical Applications of Lactoferrin (Deadline: 25 July 2024)
- 2D and 3D Culture Systems: Current Trends and Biomedical Applications (Deadline: 31 July 2024)
- Evaluation of the Antitumor Mechanism of Armed Antibodies: 2nd Edition (Deadline: 25 August 2024)
- Biological Treatment for Rheumatic Diseases (Deadline: 25 August 2024)
- Stem Cells and Organoids as Tools for Drug Development (Deadline: 31 August 2024)
- Antivirals and Targets to Fight RNA Viruses (Deadline: 31 August 2024)
- Cardiovascular Diseases: Where Do We Stand with Human-Derived Stem Cells? (Deadline: 10 September 2024)
- Neuromuscular Disorders: Current Gene and Cell Therapeutic Approaches (Deadline: 15 September 2024)
- Naturally Occurring Peptides and Proteins and Related Drugs (Deadline: 25 September 2024)
- Anabolic Androgenic Steroids and Performance-Enhancing Drugs: Forensic Aspects, Collateral Effects, and Polypharmacy (Deadline: 25 September 2024)
- Ultra-Short Peptides as Potential Drug Target Molecules in Pharmaceuticals (Deadline: 30 September 2024)
- Pluripotent Stem Cell for Novel Drug Discovery (Deadline: 22 April 2025)
- Organ Regeneration by Application of Biomaterials and Stem Cells Technology Tools (Deadline: 12 July 2025)
